መነሻ › የጡንቻ ካንሰር › North Carolina

በNorth Carolina ለየጡንቻ ካንሰር የሚደረጉ ክሊኒካዊ ጥናቶች

ለየጡንቻ ካንሰር የሚደረጉ 91 ጥናቶች በNorth Carolina ባሉ ቦታዎች ተሳታፊዎችን እየፈለጉ ነው።

በNorth Carolina ውስጥ ያሉ ከተሞች

Official study text (English)

The Vanguard Study: Testing a New Way to Screen for Cancer

UNC Lineberger Comprehensive Cancer Center, Chapel Hill
Durham VA Medical Center, Durham

ተሳታዮችን በመፈለግ ላይጤናማ ተሳታዮች ይቀበላሉ

እድሜ ከ45 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ5 ኦክቶ 2026 · NCT06995898

Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis

Comprehensive Cancer Center at Wake Forest University (CCCWFU), Winston-Salem

ተሳታዮችን በመፈለግ ላይደረጃ 2

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ5 ኦክቶ 2026 · NCT02422641

A Study of PHST001 in Advanced Solid Tumors

Duke Cancer Institute, Durham

ተሳታዮችን በመፈለግ ላይደረጃ 1

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ5 ኦክቶ 2026 · NCT06840886

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Duke University, Durham

ተሳታዮችን በመፈለግ ላይደረጃ 1/2

እድሜ 12 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT04585750

Phase IIIb Study of Ribociclib + ET in Early Breast Cancer

Duke Cancer Network, Durham
Cone Health Cancer Center, Greensboro

ተሳታዮችን በመፈለግ ላይደረጃ 3

እድሜ ከ18 እስከ 100 · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT05827081

Distance-Based Exercise to Preserve Function and Prevent Disability

Novant Health Cancer Institute - Kernersville, Kernersville
Novant Health Cancer Institute - Mount Airy, Mount Airy
Novant Health Forsyth Medical Center, Winston-Salem

ተሳታዮችን በመፈለግ ላይ

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT07059884

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

AdventHealth Infusion Center Asheville, Asheville
Southeastern Medical Oncology Center-Clinton, Clinton
AdventHealth Infusion Center Haywood, Clyde
እና 6 ተጨማሪ

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናትጤናማ ተሳታዮች ይቀበላሉ

እድሜ ከ40 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT05334069

A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer

Levine Cancer, Charlotte

ተሳታዮችን በመፈለግ ላይደረጃ 2

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ1 ኦክቶ 2026 · NCT07102381

Low Dose Aspirin for the Prevention of Postpartum Related Breast Cancer

University of North Carolina, Chapel Hill

ተሳታዮችን በመፈለግ ላይደረጃ 2ጤናማ ተሳታዮች ይቀበላሉ

እድሜ ከ18 እስከ 45 · ሴቶች · የተሻሻለው በ1 ኦክቶ 2026 · NCT05557877

A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer

UNC Hospitals, University of North Carolina at Chapel Hill, Chapel Hill

ተሳታዮችን በመፈለግ ላይደረጃ 2

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ1 ኦክቶ 2026 · NCT06369285

Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors

Carolina BioOncology Institute, LLC - Cancer Therapy and Research Center, Huntersville

ተሳታዮችን በመፈለግ ላይደረጃ 1

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ29 ሴፕቴ 2026 · NCT07360314

Radiation Therapy and Thymus Function in Young Women With Breast Cancer

Duke Cancer Center, Durham

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት

እድሜ ከ18 እስከ 50 · ሴቶች · የተሻሻለው በ29 ሴፕቴ 2026 · NCT07725172

BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors

Duke Cancer Center, Durham

ተሳታዮችን በመፈለግ ላይደረጃ 1

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ28 ሴፕቴ 2026 · NCT06120283

Evaluation of the Acceptability, Appropriateness, and Feasibility/Usability of a Metastatic Breast-cancer Specific Prognostic Calculator Among Clinicians

University of North Carolina, Chapel Hill

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናትጤናማ ተሳታዮች ይቀበላሉ

ለሁሉም እድሜ · ሁሉም ጾታዎች · የተሻሻለው በ28 ሴፕቴ 2026 · NCT05440929

A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)

Novant Health Cancer Institute ( Site 0019), Charlotte
Novant Health Oncology Specialists ( Site 0074), Winston-Salem

ተሳታዮችን በመፈለግ ላይደረጃ 3

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ28 ሴፕቴ 2026 · NCT07060807

A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)

Levine Cancer Institute ( Site 0014), Charlotte

ተሳታዮችን በመፈለግ ላይደረጃ 3

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT06312176

The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study

Levine Cancer Institute, Albemarle
Levine Cancer Institute, Charlotte
Levine Cancer Institute, Charlotte
እና 11 ተጨማሪ

ተሳታዮችን በመፈለግ ላይደረጃ 3

እድሜ 60 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT06377852

ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer

Duke Cancer Institute, Durham

ተሳታዮችን በመፈለግ ላይደረጃ 2

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT07007559

Multicenter Trial for Eliminating Breast Cancer Surgery or Radiotherapy in Exceptional Responders to Neoadjuvant Systemic Therapy

Carolinas Medical Center/Levine Cancer Institute, Charlotte

ተሳታዮችን በመፈለግ ላይ

እድሜ 30 እና ከዚያ በላይ · ሴቶች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT02945579

Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer

Atrium Levine Cancer Institute, Charlotte

ተሳታዮችን በመፈለግ ላይ

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ23 ሴፕቴ 2026 · NCT07214532

Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer

Clinical Trial Site, Charlotte
Clinical Trial Site, Durham

ተሳታዮችን በመፈለግ ላይደረጃ 3

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ23 ሴፕቴ 2026 · NCT07085767

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

Duke University Medical Center, Durham

ተሳታዮችን በመፈለግ ላይደረጃ 1

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT07213791

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

Messino Cancer Centers, Asheville
WakeMed Cancer Care - Waverly Hematology & Medical Oncology, Cary
University of North Carolina Medical Center, Chapel Hill
እና 1 ተጨማሪ

ተሳታዮችን በመፈለግ ላይደረጃ 3

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT07174336

A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer

University of North Carolina Medical Center, Chapel Hill

ተሳታዮችን በመፈለግ ላይደረጃ 2

እድሜ 18 እና ከዚያ በላይ · ሴቶች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT07287098

A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer

Atrium Health, Charlotte

ተሳታዮችን በመፈለግ ላይደረጃ 3

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ21 ሴፕቴ 2026 · NCT05894239

Identifying Patterns in the Breath of Individuals With Breast Cancer

Duke University Medical Cente, Durham

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናትጤናማ ተሳታዮች ይቀበላሉ

እድሜ ከ40 እስከ 74 · ሴቶች · የተሻሻለው በ18 ሴፕቴ 2026 · NCT06512350

Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies

Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill

ተሳታዮችን በመፈለግ ላይደረጃ 2

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ18 ሴፕቴ 2026 · NCT07340541

ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer

Oncology Specialists of Charlotte Pa, Charlotte
Carolina Oncology Specialists, Charlotte

ተሳታዮችን በመፈለግ ላይደረጃ 3

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ17 ሴፕቴ 2026 · NCT07173751

Pharmacologic Therapies to Mitigate Radiation- Associated Heart Disease

Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill, Chapel Hill

ተሳታዮችን በመፈለግ ላይደረጃ 2

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ17 ሴፕቴ 2026 · NCT07685938

Utility of a Mobile Application for Young Women With Breast Cancer

Atrium Health Levine Cancer, Charlotte

ተሳታዮችን በመፈለግ ላይ

እድሜ ከ18 እስከ 45 · ሴቶች · የተሻሻለው በ15 ሴፕቴ 2026 · NCT07009093

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

Duke Cancer Institute, Durham
Cape Fear Valley Medical Center, Fayetteville
Cone Health Cancer Center at Wesley Long, Greensboro

ተሳታዮችን በመፈለግ ላይደረጃ 3

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ15 ሴፕቴ 2026 · NCT06492616

Integrating Biological, Clinical, and Behavioral Factors to Improve Breast Cancer Outcomes - Carolina Breast Cancer Study

University of North Carolina at Chapel Hill, Chapel Hill

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት

እድሜ ከ20 እስከ 74 · ሴቶች · የተሻሻለው በ14 ሴፕቴ 2026 · NCT07214610

A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies

Research Site, Charlotte

ተሳታዮችን በመፈለግ ላይደረጃ 1/2

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ11 ሴፕቴ 2026 · NCT05123482

A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer

Duke Cancer Institute, Durham

ተሳታዮችን በመፈለግ ላይደረጃ 1/2

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ10 ሴፕቴ 2026 · NCT03424005

A Phase 1/1b Study of IAM1363 in HER2 Cancers

Duke Cancer Institute, Durham

ተሳታዮችን በመፈለግ ላይደረጃ 1

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ9 ሴፕቴ 2026 · NCT06253871

A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer

Levine Cancer Institute, Charlotte
Novant Health Cancer Institute, Charlotte
Novant Health Oncology Specialists, Winston-Salem

ተሳታዮችን በመፈለግ ላይደረጃ 1/2

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ8 ሴፕቴ 2026 · NCT07100106

Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration

Duke Cancer Institute, Durham

ተሳታዮችን በመፈለግ ላይደረጃ 1/2

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ4 ሴፕቴ 2026 · NCT05315700

A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer

Novant Health Cancer Institute, Charlotte
Duke Cancer Institute, Durham
Novant Health Cancer Institute, Winston-Salem

ተሳታዮችን በመፈለግ ላይደረጃ 3

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ3 ሴፕቴ 2026 · NCT06790693

Toci +/- SOC Chemo for Metastatic Triple Negative and ER-positive, HER2-negative Breast Cancers

Duke University, Durham

ተሳታዮችን በመፈለግ ላይደረጃ 2

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ3 ሴፕቴ 2026 · NCT05846789

Ultra Hypo-fractionated Adjuvant Whole Breast Radiation Therapy With Simultaneous Integrated Boost for Early-Stage Breast Cancer (H-ASSIST)

University of North Carolina, Chapel Hill

ተሳታዮችን በመፈለግ ላይደረጃ 2

እድሜ 50 እና ከዚያ በላይ · ሴቶች · የተሻሻለው በ3 ሴፕቴ 2026 · NCT06902311

ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ6 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።